X-CAP improves pathogenicity prediction of stopgain variants.

Abstract excerpt

Stopgain substitutions are the third-largest class of monogenic human disease mutations and often examined first in patient exomes. Existing computational stopgain pathogenicity predictors, however, exhibit poor performance at the high sensitivity required for clinical use. Here, we introduce a new classifier, termed X-CAP, which uses a novel training methodology and unique feature set to improve the AUROC by 18%...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Computational Biology
• Share to Exome
• Share to Mutation